141 related articles for article (PubMed ID: 12581210)
1. Complex alternative splicing of the hKLK3 gene coding for the tumor marker PSA (prostate-specific-antigen).
Heuzé-Vourc'h N; Leblond V; Courty Y
Eur J Biochem; 2003 Feb; 270(4):706-14. PubMed ID: 12581210
[TBL] [Abstract][Full Text] [Related]
2. Characterization of PSA-RP2, a protein related to prostate-specific antigen and encoded by alternative hKLK3 transcripts.
Heuzé-Vourc'h N; Leblond V; Olayat S; Gauthier F; Courty Y
Eur J Biochem; 2001 Aug; 268(16):4408-13. PubMed ID: 11502200
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning and expression of an alternative hKLK3 transcript coding for a variant protein of prostate-specific antigen.
Heuzé N; Olayat S; Gutman N; Zani ML; Courty Y
Cancer Res; 1999 Jun; 59(12):2820-4. PubMed ID: 10383139
[TBL] [Abstract][Full Text] [Related]
4. Unusual alternative splicing within the human kallikrein genes KLK2 and KLK3 gives rise to novel prostate-specific proteins.
David A; Mabjeesh N; Azar I; Biton S; Engel S; Bernstein J; Romano J; Avidor Y; Waks T; Eshhar Z; Langer SZ; Lifschitz-Mercer B; Matzkin H; Rotman G; Toporik A; Savitsky K; Mintz L
J Biol Chem; 2002 May; 277(20):18084-90. PubMed ID: 11834722
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.
Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H
Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910
[TBL] [Abstract][Full Text] [Related]
6. Expression of the gene coding for human prostate-specific antigen and related hGK-1 in benign and malignant tumors of the human prostate.
Henttu P; Lukkarinen O; Vihko P
Int J Cancer; 1990 Apr; 45(4):654-60. PubMed ID: 1691151
[TBL] [Abstract][Full Text] [Related]
7. Detection of prostate cancer cells circulating in peripheral blood by reverse transcription-PCR for hKLK2.
Kawakami M; Okaneya T; Furihata K; Nishizawa O; Katsuyama T
Cancer Res; 1997 Oct; 57(19):4167-70. PubMed ID: 9331068
[TBL] [Abstract][Full Text] [Related]
8. Expression of PSA-RP2, an alternatively spliced variant from the PSA gene, is increased in prostate cancer tissues but the protein is not secreted from prostate cancer cells.
Whitbread AK; Veveris-Lowe TL; Dong Y; Tan OL; Gardiner R; Samaratunga HM; Nicol DL; Clements JA
Biol Chem; 2010 Apr; 391(4):461-6. PubMed ID: 20180647
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and characterization of novel prostate antigen cDNA's.
Riegman PH; Klaassen P; van der Korput JA; Romijn JC; Trapman J
Biochem Biophys Res Commun; 1988 Aug; 155(1):181-8. PubMed ID: 2458104
[TBL] [Abstract][Full Text] [Related]
10. Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5' promoter region of the gene.
Murtha P; Tindall DJ; Young CY
Biochemistry; 1993 Jun; 32(25):6459-64. PubMed ID: 7686046
[TBL] [Abstract][Full Text] [Related]
11. Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels.
Cramer SD; Chang BL; Rao A; Hawkins GA; Zheng SL; Wade WN; Cooke RT; Thomas LN; Bleecker ER; Catalona WJ; Sterling DA; Meyers DA; Ohar J; Xu J
J Natl Cancer Inst; 2003 Jul; 95(14):1044-53. PubMed ID: 12865450
[TBL] [Abstract][Full Text] [Related]
12. A comparative analysis of prostate-specific antigen gene sequence in benign and malignant prostate tissue.
Baffa R; Moreno JG; Monne M; Veronese ML; Gomella LG
Urology; 1996 Jun; 47(6):795-800. PubMed ID: 8677566
[TBL] [Abstract][Full Text] [Related]
13. Changes in prostate-specific antigen (PSA) level correlate with growth inhibition of prostate cancer cells treated in vitro with a novel anticancer drug, irofulven.
Woynarowska BAHigdon AL; Muñoz RM; Bushong P; Waters SJ
Invest New Drugs; 2001; 19(4):283-91. PubMed ID: 11561687
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein.
Young CY; Andrews PE; Montgomery BT; Tindall DJ
Biochemistry; 1992 Jan; 31(3):818-24. PubMed ID: 1370633
[TBL] [Abstract][Full Text] [Related]
15. Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line.
Henttu P; Liao SS; Vihko P
Endocrinology; 1992 Feb; 130(2):766-72. PubMed ID: 1370795
[TBL] [Abstract][Full Text] [Related]
16. A novel form of prostate-specific antigen transcript produced by alternative splicing.
Tanaka T; Isono T; Yoshiki T; Yuasa T; Okada Y
Cancer Res; 2000 Jan; 60(1):56-9. PubMed ID: 10646852
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patients.
Ylikoski A; Karp M; Pettersson K; Lilja H; Lövgren T
J Mol Diagn; 2001 Aug; 3(3):111-22. PubMed ID: 11486050
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the C-terminal end of the prostrate-specific antigen in a conformational epitope: characterization by proteolytic degradation of monoclonal antibody-bound antigen and mass spectrometry.
Michel S; Forest E; Pétillot Y; Deléage G; Heuzé-Vourc'h N; Courty Y; Lascoux D; Jolivet M; Jolivet-Reynaud C
J Mol Recognit; 2001; 14(6):406-13. PubMed ID: 11757074
[TBL] [Abstract][Full Text] [Related]
19. Autocrine regulation of prostate-specific antigen gene expression in a human prostatic cancer (LNCaP) subline.
Hsieh JT; Wu HC; Gleave ME; von Eschenbach AC; Chung LW
Cancer Res; 1993 Jun; 53(12):2852-7. PubMed ID: 7684949
[TBL] [Abstract][Full Text] [Related]
20. Cloning and sequencing of the cynomolgus monkey prostate specific antigen cDNA.
Marshall DJ; Rudnick KA; Lu J; Snyder LA
J Med Primatol; 2006 Feb; 35(1):12-7. PubMed ID: 16430490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
